0000899243-20-012644.txt : 20200511 0000899243-20-012644.hdr.sgml : 20200511 20200511183951 ACCESSION NUMBER: 0000899243-20-012644 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200507 FILED AS OF DATE: 20200511 DATE AS OF CHANGE: 20200511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIKULICH RAYMOND C CENTRAL INDEX KEY: 0001179696 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37980 FILM NUMBER: 20866488 MAIL ADDRESS: STREET 1: 2100 REXFORD ROAD STREET 2: SUITE 414 CITY: CHARLOTTE STATE: NC ZIP: 28211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Colony Capital, Inc. CENTRAL INDEX KEY: 0001679688 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 464591526 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 515 SOUTH FLOWER STREET STREET 2: 44TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 310-282-8820 MAIL ADDRESS: STREET 1: 515 SOUTH FLOWER STREET STREET 2: 44TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: Colony NorthStar, Inc. DATE OF NAME CHANGE: 20160714 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-07 0 0001679688 Colony Capital, Inc. CLNY 0001179696 MIKULICH RAYMOND C C/O COLONY CAPITAL, INC. 515 S. FLOWER ST., 44TH FLOOR LOS ANGELES CA 90071 1 0 0 0 Deferred Stock 2020-05-07 4 A 0 81219 A Class A Common Stock 81219 124074 D Represents the receipt of deferred stock units ("Deferred Stock") granted by the Issuer in respect of the reporting person's election to defer equity compensation payable in accordance with the Issuer's non-executive director compensation policy in connection with the reporting person's recent re-election to the Issuer's board of directors. Deferred Stock has no expiration date and is payable in the Issuer's Class A Common Stock, on a one-for-one basis, after the reporting person's separation from service with the Issuer. The Deferred Stock is scheduled to vest on May 7, 2021. The amount of Deferred Stock was determined by dividing the fixed grant value of $160,000 by the closing price of the Issuer's common stock on the New York Stock Exchange on the business day prior to the grant date. /s/ Jenny B. Neslin, as Attorney-in-fact 2020-05-11